Search
for
Sort by
Research 241–270 of 1000+
- Ayurvedic Rasayan formulations having potential for managing post COVID ailments- a narrative review
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- The immune response to COVID‐19: Does sex matter?
- Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants
- Undesirable effects of COVID-19 vaccination on Saudi population: A descriptive study, Winter 2022.
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- A comprehensive review of etiology, pathophysiologyepidemiology, and management of hair loss and its correlation with COVID-19
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Alopecia Areata after COVID-19 Vaccines
- Long-COVID symptoms after multisystem inflammatory syndrome in children during different pandemic waves
- Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?
- How does covid-19 affect the skin?
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- The Pathological Culprit of Neuropathic Skin Pain in Long COVID-19 Patients: A Case Series
- COVID-19-associated Telogen Effluvium After Hospital Discharge: A Prospective Cohort Study.
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- Androgen sensitivity gateway to COVID‐19 disease severity
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- Dermatological Manifestations of COVID-19 in Children
- Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
- SYMPTOMATOLOGY AND TREATMENT OF COVID-19 AFFECTING SKIN APPENDAGES: A NARRATIVE REVIEW BEYOND COVID-TOES.
- More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes
- Efficacy of Dr. SKS hair booster serum for the treatment of hair loss in COVID-19 induced persistent telogen effluvium
- COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial